An Android screening app trained on Indonesian survey data used XGBoost and SHAP to explain dysglycemia risk, achieving a ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven) on Saturday presented preclinical data for BHV-1420 in an oral presentation at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results